
Epstein Barr Virus: Development of Vaccines and Immune Cell
2021年10月8日 · Epstein-Barr virus (EBV) is the first human tumor virus discovered and is strongly implicated in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated cancers account for over 200,000 new cases of cancer and cause 150,000 deaths world-wide. EBV is also the primary cause …
Epstein-Barr Virus (EBV): Biology and Clinical Disease - PMC
In this review, we discuss the lifecycle of EBV, the various functions of EBV encoded proteins and RNAs, the ability of the virus to activate and evade immune responses, as well as the neoplastic and autoimmune diseases that are associated with EBV infection in the human population.
Epstein Barr Virus: Development of Vaccines and Immune Cell …
Epstein-Barr virus (EBV) is the first human tumor virus discovered and is strongly implicated in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated cancers account for over 200,000 new cases of cancer and cause 150,000 deaths world-wide.
The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine ...
2021年6月8日 · Epstein-Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases.
The Status and Prospects of Epstein–Barr Virus ... - Frontiers
2021年6月7日 · Epstein–Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases.
Main Targets of Interest for the Development of a Prophylactic or ...
2021年6月22日 · Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90% of the planet's adult population is infected. Symptomatic primary infection by this Herpesviridae corresponds to infectious mononucleosis (IM), which is generally a benign disease.
Targeting the signaling in Epstein–Barr virus-associated diseases ...
2021年1月12日 · In this review, we summarize and discuss some recent exciting discoveries in EBV research area, which including DNA methylation alterations, metabolic reprogramming, the changes of mitochondria...
Incidence and trend of Epstein-Barr virus-related cancer: A ...
2021年5月28日 · In this study, we aimed to analyze the incidence and the trend of incidence of these virus-related cancer and to identify whether the trend was similar between them. Methods: This was a retrospective analysis based on the data from Surveillance, Epidemiology, and End Results (18 registries, 2000-2017), which totally included 71,415 patients.
Epstein-Barr virus: Biology and clinical disease
2022年9月29日 · EBV infects over 95% of the world’s population and is a highly successful pathogen. Primary infection is often asymptomatic and occurs at a young age in developing countries and at a later age in more industrialized countries (Gewurz et al., 2021). EBV is intermittently shed in saliva in healthy individuals.
Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive ...
2021年11月5日 · Chronic viral infections, such as EBV, also result in T-cell exhaustion that can be reversed by PD-1 blockade. Nivolumab is a fully human IgG4 monoclonal anti-PD-1 antibody which has demonstrated activity and favorable safety in lymphoid malignancies.
- 某些结果已被删除